New contrast media formulations currently progressing through our development and regulatory pipeline.
| S.No. | Product | Presentation | Strength |
|---|---|---|---|
| 1 | Gadobenate Dimeglumine Injection | Vial | 529 mg/mL |
| 2 | Iopromide Injection | Vial | 300 & 370 mg I/mL |
| 3 | Gadoxetate Disodium Injection | Vial | 181.43 mg/mL |
All upcoming products are subject to regulatory approval and may change during development.
Connect with our medical team to learn more about our development pipeline.
Contact Us